Withdrawn Notice: Nanocarriers’- An Efficient Drug Delivery System for Neurodegenerative Disorders Including Alzheimer’s, Parkinson’s, Huntington, Amyotrophic Lateral Sclerosis and Associated Risk of Nanocarriers, Future Perspectives - A Review

Title:Withdrawn Notice: Nanocarriers’- An Efficient Drug Delivery System for Neurodegenerative Disorders Including Alzheimer’s, Parkinson’s, Huntington, Amyotrophic Lateral Sclerosis and Associated Risk of Nanocarriers, Future Perspectives - A Review

Volume: 23

Author(s): Sumel Ashique*

Affiliation:

• Department of Pharmaceutics, Bharat Institute of Technology (BIT-School of Pharmacy), Meerut-250103, UP, India

Abstract: The article has been withdrawn at the request of the authors and editor of the journal Current Drug Targets.

Bentham Science apologizes to the readers of the journal for any inconvenience this may have caused.

The Bentham Editorial Policy on Article Withdrawal can be found at https://benthamscience.com/editorial-policies-main.php

Bentham Science Disclaimer:

It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. Furthermore, any data, illustration, structure or table that has been published elsewhere must be reported, and copyright permission for reproduction must be obtained. Plagiarism is strictly forbidden, and by submitting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism or fabricated information is discovered. By submitting a manuscript, the authors agree that the copyright of their article is transferred to the publishers if and when the article is accepted for publication.

Cite this article as:

Ashique Sumel*, Withdrawn Notice: Nanocarriers’- An Efficient Drug Delivery System for Neurodegenerative Disorders Including Alzheimer’s, Parkinson’s, Huntington, Amyotrophic Lateral Sclerosis and Associated Risk of Nanocarriers, Future Perspectives - A Review, Current Drug Targets 2022; 23 () . https://dx.doi.org/10.2174/1389450123666220131104947